Method Transfer from an Agilent 1100 Series LC to an Agilent 1260 Infinity II LC

Significance of the topic

Instrument-to-instrument method transfer is critical in pharmaceutical quality control because re-validation on a new LC system consumes significant time and resources. Penicillin antibiotics remain among the most commonly used antibacterial agents, making robust, transferable assays essential for regulatory compliance and routine testing.

Objectives and overview of the study

This application note demonstrates the transfer of a conventional HPLC method for penicillin-like antibacterials from an Agilent 1100 Series Binary LC to the Agilent 1260 Infinity II LC, verifying equivalency in retention times and resolution. It further explores the adaptation of this method to UHPLC conditions on the 1260 Infinity II to achieve faster analyses and lower solvent consumption.

Instrumention

• Agilent 1100 Series Binary LC: binary pump, degasser, autosampler, thermostatted column compartment, diode array detector.
• Agilent 1260 Infinity II LC: binary pump, vial sampler with integrated column compartment and cooler, diode array detector.
• Columns: ZORBAX Eclipse Plus C18 (4.6 × 150 mm, 5 μm) and InfinityLab Poroshell 120 EC-C18 (4.6 × 100 mm, 2.7 μm).
• Reagents: LC-grade acetonitrile; ultrapure water from Milli-Q; KH₂PO₄, phosphoric acid; amoxicillin, ampicillin, penicillin G and V standards.
• Software: Agilent OpenLAB CDS v2.1 for instrument control and data processing.

Methodology

The conventional HPLC protocol used a gradient of 25 mM KH₂PO₄ (pH 3) and acetonitrile, rising from 5 % to 60 % organic over 24 min at 1.5 mL/min and 40 °C, with UV detection at 204 nm. For UHPLC, the same mobile phases and gradient profile were compressed into an 8 min run at 3.0 mL/min on a superficially porous column, with shortened equilibration.

Main results and discussion

• Retention times matched between the 1100 Series and 1260 Infinity II within 0.6 % deviation, confirming seamless method transfer.
• Ten-run precision studies on both systems yielded retention time RSDs below 0.1 % and area RSDs under 0.5 %, with resolution values exceeding pharmacopeial requirements.
• Under UHPLC conditions, analysis time decreased by 67 % and solvent usage by 33 %, while critical peak resolution was maintained or improved.

Benefits and practical applications

Laboratories can adopt the 1260 Infinity II LC without revalidating existing penicillin assays, saving time and reducing operational costs. The UHPLC variant further boosts throughput and lowers solvent consumption, making it ideal for high-volume pharmaceutical QC and routine analysis.

Future trends and possibilities for application

Applying this transfer strategy to other antibiotic classes and small molecules can harmonize analytical workflows across instrument generations. Integration with automated sample handling and advanced data management will streamline migrations. Emerging column chemistries and higher pressure capabilities will further accelerate separations and enhance impurity profiling.

Conclusion

The Agilent 1260 Infinity II LC reproduces the performance of the Agilent 1100 Series Binary LC for penicillin analysis with equivalent precision and resolution. Transitioning to UHPLC on the 1260 Infinity II delivers substantial gains in speed and solvent efficiency without compromising data quality, illustrating a clear pathway for modernizing pharmaceutical LC methods.

Reference

1. Rambla-Alegre et al. J. Chromatogr. A 2011, 1218, 4972–4981.
2. Bailón-Pérez et al. J. Chromatogr. A 2009, 1216, 8355–8361.
3. Dousa and Hosmanová. J. Pharm. Biomed. Anal. 2005, 37, 373–377.
4. Agilent Technologies. Agilent 1290 Infinity with ISET, User Manual G4220-90314, 2015.